Similar articles

• Editorial comment.

  Kassouf W. Kassouf W. J Urol. 2010 Aug;184(2):469. doi: 10.1016/j.juro.2010.03.162. Epub 2010 Jun 17. J Urol. 2010. PMID: 20620400 No abstract available.
• [T1 G3 bladder tumors: the respective role of BCG and cystectomy].

  Pfister C, Landé P, Hervé JM, Barré P, Barbagelatta M, Camey M, Botto H. Pfister C, et al. Prog Urol. 1995 Apr;5(2):231-7. Prog Urol. 1995. PMID: 7719369 French.
• [Treatment and follow-up of superficial bladder cancer].

  Raitanen M. Raitanen M. Duodecim. 2002;118(9):903-9. Duodecim. 2002. PMID: 12238168 Review. Finnish. No abstract available.
• [Clinical study of primary carcinoma in situ of the bladder].

  Mori Y, Shima H, Ihara H, Yabumoto H, Taguchi K, Koike H, Nojima M, Yamamoto H, Ikoma F. Mori Y, et al. Hinyokika Kiyo. 1996 Jan;42(1):17-21. Hinyokika Kiyo. 1996. PMID: 8686577 Japanese.
• The optimal management of T1G3 bladder cancer.

  Emiliozzi P, Pansadoro A, Pansadoro V. Emiliozzi P, et al. BJU Int. 2008 Nov;102(9 Pt B):1265-73. doi: 10.1111/j.1464-410X.2008.07969.x. BJU Int. 2008. PMID: 19035891 Review. No abstract available.